| study |
Radiation dose |
Chemotherapy |
Median survival |
2-year survival |
5-year survival |
local recurrence |
| |
(Gy) |
|
(mo) |
(%) |
(%) |
(%) |
| Herskovic [14] |
50 |
CDDP+5FU |
14.1 |
38% |
26 |
46 |
| Hironaka and Ohtsu [11] |
60 |
CDDP+5FU |
33 |
49(3-year) |
46 |
|
| Stahl [9] |
40(+Surgery) |
CDDP+5FU+Etoposide |
16.4 |
39.9 |
31.3(3-year) |
|
| |
65 |
CDDP+5FU+Etoposide |
14.9 |
35.4 |
24.4(3-year) |
51 |
| Minsky [16] |
50.4 |
CDDP+5FU |
18.1 |
40 |
|
52 |
| |
64.8 |
CDDP+5FU |
13 |
31 |
|
56 |
|
